{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:25:03Z","timestamp":1794018303067,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.humpath.2026.106209","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:05:34Z","timestamp":1783119934000},"page":"106209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TRPS1 and GATA3 expression in BRG1\/SMARCA4-deficient malignant neoplasms"],"prefix":"10.1016","volume":"177","author":[{"given":"Jing","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annikka","family":"Weissferdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106209_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217811","article-title":"SMARCA4: promises and challenges in the treatment of cancers","volume":"625","author":"Ye","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2026.106209_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162675","article-title":"Clinical characteristics and outcomes of SMARCA4-Mutated or deficient malignancies: a systematic review of case reports and series","volume":"17","author":"Ohta","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106209_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00428-025-04318-9","article-title":"An update on the role of SMARCA4 deficiency in gynecological neoplasms: how and where","volume":"488","author":"Maccio","year":"2026","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106209_bib4","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S565394","article-title":"Clinicopathological and genomic analysis of SMARCA4-Deficient non-small cell lung cancer: a retrospective cohort study","volume":"18","author":"Chen","year":"2026","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.humpath.2026.106209_bib5","article-title":"The role of SMARCA4 in lung cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2026.106209_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10120-024-01510-9","article-title":"SMARCA4-deficient undifferentiated gastric carcinoma: a case series and literature review","volume":"27","author":"An","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.humpath.2026.106209_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.5858\/arpa.2021-0001-OA","article-title":"SMARCA4\/BRG1-Deficient sinonasal carcinoma","volume":"146","author":"Kakkar","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2026.106209_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106209_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.semdp.2021.06.001","article-title":"Recent updates in thoracic SMARCA4-deficient undifferentiated tumor","volume":"38","author":"Nambirajan","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.5858\/arpa.2022-0411-OA","article-title":"Trichorhinophalangeal syndrome type 1 is a highly sensitive and specific marker for diagnosing triple-negative breast carcinomas on cytologic samples","volume":"148","author":"Lynn","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2026.106209_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/his.15126","article-title":"TRPS1 is a promising marker for all subtypes of breast cancer","volume":"84","author":"Lui","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106209_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.humpath.2022.04.006","article-title":"TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma","volume":"125","author":"Yoon","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41379-020-00692-8","article-title":"TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer","volume":"34","author":"Ai","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.anndiagpath.2014.12.001","article-title":"GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin","volume":"19","author":"Wendroth","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/his.12645","article-title":"GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry","volume":"67","author":"Huo","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106209_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dc.23206","article-title":"Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens","volume":"43","author":"Braxton","year":"2015","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2026.106209_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.humpath.2008.09.010","article-title":"The significance of GATA3 expression in breast cancer: a 10-year follow-up study","volume":"40","author":"Ciocca","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17183092","article-title":"BRG1 loss is frequent in lung cancer and transforms lung epithelial cells via transcriptional and epigenetic reprograming","volume":"17","author":"Tessema","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106209_bib19","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jcp-2024-209619","article-title":"Unravelling switch\/sucrose non-fermentable (SWI-SNF) complex-deficient thoracic tumours: a clinicopathological comparative on undifferentiated tumours and non-small cell lung carcinomas with BRG1 and BRM deficiency","volume":"78","author":"Sood","year":"2025","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5858\/arpa.2019-0633-OA","article-title":"SMARCA4\/BRG1-Deficient non-small cell lung carcinomas: a case series and review of the literature","volume":"145","author":"Nambirajan","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2026.106209_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/his.14612","article-title":"Switch\/sucrose-non-fermentable (SWI\/SNF) complex (SMARCA4, SMARCA2, INI1\/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas","volume":"80","author":"Ahadi","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106209_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13000-021-01091-6","article-title":"Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review","volume":"16","author":"Duan","year":"2021","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cjp2.188","article-title":"SWI\/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma","volume":"7","author":"Tessier-Cloutier","year":"2021","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.humpath.2026.106209_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semdp.2020.08.003","article-title":"SWI\/SNF-deficient malignancies of the female genital tract","volume":"38","author":"McCluggage","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib26","article-title":"Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"2","author":"Ramos","year":"2014","journal-title":"Rare Dis"},{"key":"10.1016\/j.humpath.2026.106209_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106209_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.5705","article-title":"SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type","volume":"255","author":"Andrianteranagna","year":"2021","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib29","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41379-019-0303-z","article-title":"SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association","volume":"32","author":"Lin","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.semdp.2020.11.001","article-title":"SWI\/SNF-deficient cancers of the Gastroenteropancreatic tract: an in-depth review of the literature and pathology","volume":"38","author":"Nowak","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PGP.0000000000000996","article-title":"SMARCA4\/BRG1 -deficient uterine neoplasm with hybrid adenosarcoma and carcinoma features: expanding the molecular-morphologic spectrum of SMARCA4 -driven gynecologic malignancies","volume":"43","author":"Wei","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-Deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2026.106209_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","article-title":"SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses","volume":"43","author":"Perret","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106209_bib34","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/oncolo\/oyae218","article-title":"Genomic landscape of malignant phyllodes tumors reveals multiple targetable opportunities","volume":"29","author":"Rosenberger","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.humpath.2026.106209_bib35","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41379-021-00837-3","article-title":"Histologic and genomic features of breast cancers with alterations affecting the SWI\/SNF (SMARC) genes","volume":"34","author":"Schwartz","year":"2021","journal-title":"Mod Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:43:47Z","timestamp":1794015827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":35,"alternative-id":["S0046817726001784"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106209","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRPS1 and GATA3 expression in BRG1\/SMARCA4-deficient malignant neoplasms","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106209"}}